A Swiss AI company just demonstrated the kind of explosive growth that gets international investors’ attention. Delvitech, which develops AI-native solutions for automated optical inspection in el...
Read More
As a lead candidate in BioVersys’ portfolio, BV100 is a novel formulation of rifabutin suitable for intravenous administration, with a recently discovered novel mode of action showing an active up...
Read More
The global energy transition cannot happen without batteries. Yet, conventional technology faces fundamental constraints, including a reliance on scarce raw materials, long charging times, and com...
Read More
Following an initial investment of USD 15 million in 2024, AstraZeneca has acquired Basel-based SixPeaks Bio AG. SixPeaks is investigating potential therapies for weight-managemen...
Read More
Bigger Cakes and Smaller Slices With a name like redalpine, a powerful symbol of a rising sun amidst the impressive peaks of the Swiss alps, you would think that the kind of patriotism running thr...
Read More
Coming to Play Michael Sidler likes to describe redalpine as a “one-stop shop” for founders. “We don’t only provide money,” he says. “We provide infrastructure, networks, sparring partners, and ex...
Read More